Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Lifecare AS ( (DE:LFC0) ).
Lifecare ASA has filed new patent applications in Europe and the United States for surface acoustic wave (SAW) sensing technology, enhancing its continuous glucose monitoring (CGM) systems. This development supports the company’s strategy of miniaturizing implantable sensors, potentially improving sensitivity and production efficiency, and positions Lifecare for further advancements in the MedTech industry.
More about Lifecare AS
Lifecare ASA is a MedTech company specializing in the development of next-generation continuous glucose monitoring (CGM) systems. The company focuses on using osmotic pressure as a sensing principle to monitor various body analytes, aiming to bring advanced CGM technology to market. Lifecare’s sensor technology is applicable for detecting a wide range of analytes and molecules in humans and pets.
Average Trading Volume: 366,886
Current Market Cap: NOK192.5M
For a thorough assessment of LFC0 stock, go to TipRanks’ Stock Analysis page.